Investing.com - Financial Markets Worldwide

Beijing Sun Novo Pharmaceutical Research Co Ltd (688621)

Shanghai
Currency in CNY
69.32
-2.03(-2.85%)
Closed·
688621 Scorecard
Full Analysis
Net income is expected to grow this year
Trading near 52-week High
Earnings results expected in 0 days
688621 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
68.5974.65
52 wk Range
28.9074.65
Key Statistics
Edit
Bid/Ask
69.30 / 69.32
Prev. Close
71.35
Open
72.13
Day's Range
68.59-74.65
52 wk Range
28.9-74.65
Volume
5.74M
Average Volume (3m)
5.54M
1-Year Change
86.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688621 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 14
RSI suggests the stock is in overbought territory
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Beijing Sun Novo Pharmaceutical Research Co Ltd Company Profile

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
1556
Market
China

Compare 688621 to Peers and Sector

Metrics to compare
688621
Peers
Sector
Relationship
P/E Ratio
56.4x40.2x−0.5x
PEG Ratio
−1.600.670.00
Price/Book
7.4x3.8x2.6x
Price / LTM Sales
7.2x6.5x3.3x
Upside (Analyst Target)
-0.8%40.3%
Fair Value Upside
Unlock10.8%4.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.20%
Dividend Yield
0.23%
Industry Median 0.85%
Annualised payout
0.16
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.27 / --
Revenue / Forecast
230.84M / --
EPS Revisions
a
a
Unlock
Last 90 days

688621 Income Statement

FAQ

What Stock Exchange Does Beijing Sun Novo Pharmaceutical Research Trade On?

Beijing Sun Novo Pharmaceutical Research is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Beijing Sun Novo Pharmaceutical Research?

The stock symbol for Beijing Sun Novo Pharmaceutical Research is "688621."

What Is the Beijing Sun Novo Pharmaceutical Research Market Cap?

As of today, Beijing Sun Novo Pharmaceutical Research market cap is 7.80B.

What Is Beijing Sun Novo Pharmaceutical Research's Earnings Per Share (TTM)?

The Beijing Sun Novo Pharmaceutical Research EPS (TTM) is 1.20.

When Is the Next Beijing Sun Novo Pharmaceutical Research Earnings Date?

Beijing Sun Novo Pharmaceutical Research will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is 688621 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Beijing Sun Novo Pharmaceutical Research Stock Split?

Beijing Sun Novo Pharmaceutical Research has split 1 times.

How Many Employees Does Beijing Sun Novo Pharmaceutical Research Have?

Beijing Sun Novo Pharmaceutical Research has 1556 employees.

What is the current trading status of Beijing Sun Novo Pharmaceutical Research (688621)?

As of 14 Aug 2025, Beijing Sun Novo Pharmaceutical Research (688621) is trading at a price of 69.32, with a previous close of 71.35. The stock has fluctuated within a day range of 68.59 to 74.65, while its 52-week range spans from 28.90 to 74.65.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.